Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Anticoagulants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global anticoagulants market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Blood clots form when blood thickens and forms a semi-solid mass in any part of the body. This causes serious problems, such as stroke, heart attack, pulmonary embolism, transient ischemic attacks, and deep vein thrombosis (DVT). As a result, doctors around the world are prescribing anticoagulant drugs to people who are at a high risk of clot formation. These drugs help in thinning blood, preventing or reducing blood clotting, and prolonging the clotting time. They are usually available in capsule or tablet form, including warfarin, rivaroxaban, dabigatran, and apixaban.

Anticoagulants Market Trends:

Recent research indicates that hypercoagulability in individuals affected by the coronavirus disease (COVID-19) pandemic can be one of the leading causes of mortality worldwide. As a result, its surging cases are positively influencing the demand for anticoagulant drugs to treat the thrombotic condition among critically ill or hospitalized patients. Moreover, certain risk factors, such as extended sitting, smoking, trauma, blood disorders, and autoimmune diseases, can cause blood clotting in different parts of the body. This, in confluence with the increasing prevalence of human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, and chronic inflammation, represents another significant factor strengthening the growth of the market. Apart from this, the growing aging population across the globe is resulting in the escalating demand for surgical services. Surgeries often require prolonged bed rest, which, in turn, increases the risk of blood clotting and the overall sales of anticoagulant drugs. Furthermore, the improving diagnosis rates and the escalating demand for target therapeutics are fueling the market growth. The emergence of online pharmacies is also driving the demand for anticoagulant drugs around the world.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anticoagulants market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on drug class, route of administration, distribution channel and application.

Breakup by Drug Class:

  • Novel Oral Anticoagulants (NOACs)
  • Heparin and Low Molecular Weight Heparin (LMWH)
  • Vitamin K Antagonist
  • Others
     

Breakup by Route of Administration:

  • Oral Anticoagulant
  • Injectable Anticoagulant
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others
     

Breakup by Application:

  • Atrial Fibrillation and Heart Attack
  • Stroke
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc. and Sanofi.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Drug Class, Route of Administration, Distribution Channel, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc. and Sanofi.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global anticoagulants market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global anticoagulants market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anticoagulants market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Anticoagulants Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Class
    6.1    Novel Oral Anticoagulants (NOACs)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Heparin and Low Molecular Weight Heparin (LMWH)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Vitamin K Antagonist
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Route of Administration
    7.1    Oral Anticoagulant
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Injectable Anticoagulant
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Application
    9.1    Atrial Fibrillation and Heart Attack
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Stroke
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Deep Vein Thrombosis (DVT)
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Pulmonary Embolism (PE)
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Alexion Pharmaceuticals Inc
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Aspen Holdings
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Boehringer Ingelheim International GmbH
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Bristol-Myers Squibb Company
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Daiichi Sankyo Company Limited
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Dr. Reddy’s Laboratories Ltd
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    GlaxoSmithKline plc
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Johnson & Johnson Private Limited
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Sanofi
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
Figure 2: Global: Anticoagulants Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2020
Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2020
Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2020
Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2020
Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants (NOACs)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants (NOACs)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin (LMWH)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin (LMWH)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Anticoagulants (Deep Vein Thrombosis (DVT)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Anticoagulants (Deep Vein Thrombosis (DVT)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Anticoagulants (Pulmonary Embolism (PE)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Anticoagulants (Pulmonary Embolism (PE)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: North America: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: United States: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Canada: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: China: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Japan: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: India: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Australia: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Others: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Europe: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Germany: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: France: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Italy: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Spain: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Russia: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Others: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Others: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2020
Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 88: Global: Anticoagulants Industry: SWOT Analysis
Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Anticoagulants Market: Competitive Structure
Table 8: Global: Anticoagulants Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links